Amsterdam Cardiovascular Sciences

Cardiac Impact of Dapagliflozin in Severe Chronic Kidney Disease: Rationale and Design of the Renal Lifecycle Trial Cardiac Imaging Sub-studies

Karsten, M., Badve, S., Gansevoort, R. T., Berger, S. P., Heerspink, H. L., Abrahams, A. C., de Bruin-Bon, R. H. A., van Etten, R. W., Francois, K., Gelens, M. A. C. J., Hemmelder, M., van Heerebeek, L., van der Heijden, J., Kim, Y.-S., Kuypers, D., van der Leeuw, J., Ocak, G., Siegert, C., Vleut, R. & Waanders, F. & 4 others, Wang, A. Y., Vervloet, M., Arnott, C. & L, J., 27 Oct 2025, (Accepted/In press) In: Clinical Kidney Journal.

Research output: Contribution to journal › Article › Academic › peer-review

The immunometabolic profile of Human Peritoneal Macrophages and its relation to systemic inflammation and cardiac function in patients on Peritoneal Dialysis

Karsten, M., Hahn, N., Vree, P., Van den Bossche, J., Vervloet, M. & L, J., 27 Aug 2025, (In preparation) In: Biochemical and Biophysical Research Communications.

Research output: Contribution to journal › Article › Academic › peer-review

Empagliflozin prevents myocardial immune infiltration in uraemic mice exposed to peritoneal dialysis fluids.

Kane, J. A., Karsten, M., van Bergen, A. S., Lutgens, E., van den Brom, C. E., Vervloet, M., Eringa, E. C. & L, J., 10 Aug 2025, (In preparation) In: Journal of the American Heart Association.

Research output: Contribution to journal › Article › Academic › peer-review